Bempegaldesleukin (NKTR-214): a CD-122-biased IL-2 receptor agonist for cancer immunotherapy
Doberstein, Stephen K.Language:
english
Journal:
Expert Opinion on Biological Therapy
DOI:
10.1080/14712598.2019.1685489
Date:
October, 2019
File:
PDF, 923 KB
english, 2019